Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
COLO 858 | Vemurafenib | (+)-JQ1 | 0.316 | 1.000 | uM | 72 | hr | 2 | 1110 | 848 | 0.0795 | 0.0899 | 0.7640 | 0.7359 |
A-375 | Vemurafenib | Dasatinib | 0.100 | 3.160 | uM | 72 | hr | 2 | 1659 | 68 | 0.0806 | 0.0917 | 0.0410 | 0.0407 |
A-375 | Vemurafenib | Defactinib | 0.100 | 3.160 | uM | 72 | hr | 1 | 2119 | 435 | 0.0807 | 0.0825 | 0.2053 | 0.1694 |
COLO 858 | Vemurafenib | (+)-JQ1 | 3.160 | 0.000 | uM | 72 | hr | 2 | 1300 | 1033 | 0.0810 | 0.0787 | 0.7946 | 0.7868 |
COLO 858 | Vemurafenib | JNK-IN-8 | 1.000 | 0.316 | uM | 72 | hr | 1 | 1201 | 711 | 0.0813 | 0.0722 | 0.5920 | 0.5757 |
A-375 | Vemurafenib | Dasatinib | 0.100 | 3.160 | uM | 72 | hr | 3 | 1677 | 72 | 0.0813 | 0.0917 | 0.0429 | 0.0407 |
COLO 858 | Vemurafenib | Saracatinib | 0.316 | 1.000 | uM | 72 | hr | 2 | 1129 | 649 | 0.0813 | 0.0840 | 0.5748 | 0.5773 |
A-375 | Vemurafenib | Saracatinib | 3.160 | 0.316 | uM | 72 | hr | 2 | 1856 | 299 | 0.0815 | 0.0842 | 0.1611 | 0.1524 |
COLO 858 | Vemurafenib | I-BET151 | 1.000 | 1.000 | uM | 72 | hr | 1 | 1426 | 1073 | 0.0816 | 0.0720 | 0.7525 | 0.7523 |
COLO 858 | Vemurafenib | I-BET | 1.000 | 1.000 | uM | 72 | hr | 3 | 1033 | 766 | 0.0816 | 0.0928 | 0.7415 | 0.7455 |
A-375 | Vemurafenib | Saracatinib | 0.316 | 3.160 | uM | 72 | hr | 1 | 1649 | 67 | 0.0828 | 0.0757 | 0.0406 | 0.0403 |
COLO 858 | Vemurafenib | Saracatinib | 0.316 | 1.000 | uM | 72 | hr | 3 | 1140 | 648 | 0.0833 | 0.0840 | 0.5684 | 0.5773 |
COLO 858 | Vemurafenib | (+)-JQ1 | 3.160 | 1.000 | uM | 72 | hr | 1 | 1645 | 1369 | 0.0838 | 0.0609 | 0.8322 | 0.8549 |
A-375 | Vemurafenib | I-BET | 3.160 | 1.000 | uM | 72 | hr | 2 | 1594 | 450 | 0.0839 | 0.0866 | 0.2823 | 0.3091 |
A-375 | Vemurafenib | Defactinib | 0.000 | 3.160 | uM | 72 | hr | 3 | 2006 | 239 | 0.0847 | 0.0889 | 0.1191 | 0.1262 |
COLO 858 | Vemurafenib | PF562271 | 0.316 | 1.000 | uM | 72 | hr | 1 | 1035 | 564 | 0.0849 | 0.0793 | 0.5449 | 0.5384 |
A-375 | Vemurafenib | Belinostat | 0.000 | 1.000 | uM | 72 | hr | 2 | 1660 | 543 | 0.0853 | 0.0904 | 0.3271 | 0.3077 |
A-375 | Vemurafenib | Belinostat | 0.100 | 1.000 | uM | 72 | hr | 3 | 1672 | 550 | 0.0857 | 0.0930 | 0.3289 | 0.3181 |
A-375 | Vemurafenib | PF562271 | 3.160 | 1.000 | uM | 72 | hr | 2 | 1845 | 254 | 0.0865 | 0.0854 | 0.1377 | 0.1306 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 3.160 | 3.160 | uM | 72 | hr | 3 | 378 | 104 | 0.0869 | 0.1027 | 0.2751 | 0.2808 |
COLO 858 | Vemurafenib | Defactinib | 0.000 | 3.160 | uM | 72 | hr | 3 | 1265 | 531 | 0.0871 | 0.1023 | 0.4198 | 0.4297 |
COLO 858 | Vemurafenib | Saracatinib | 0.316 | 1.000 | uM | 72 | hr | 1 | 1252 | 737 | 0.0872 | 0.0840 | 0.5887 | 0.5773 |
A-375 | Vemurafenib | PF562271 | 1.000 | 1.000 | uM | 72 | hr | 3 | 1711 | 107 | 0.0873 | 0.0988 | 0.0625 | 0.0671 |
A-375 | Vemurafenib | I-BET151 | 3.160 | 1.000 | uM | 72 | hr | 2 | 1858 | 649 | 0.0874 | 0.0884 | 0.3493 | 0.3475 |
COLO 858 | Vemurafenib | PF562271 | 0.316 | 1.000 | uM | 72 | hr | 2 | 956 | 466 | 0.0884 | 0.0793 | 0.4874 | 0.5384 |